The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD
Abstract
In patients with cirrhosis, acute renal failure is mainly due to prerenal failure (caused by renal hypoperfusion) and tubular necrosis. The main causes of prerenal failure are “true hypovolemia” (induced by hemorrhage or gastrointestinal or renal fluid losses), sepsis, or type 1 hepatorenal syndrome (HRS). The frequency of prerenal failure due to the administration of nonsteroidal anti-inflammatory drugs or intravascular radiocontrast agents is unknown. Prerenal failure is rapidly reversible after restoration of renal blood flow. Treatment is directed to the cause of hypoperfusion, and fluid replacement is used to treat most cases of “non-HRS” prerenal failure. In patients with type 1 HRS with very low short-term survival rate, liver transplantation is the ideal treatment. Systemic vasoconstrictor therapy (with terlipressin, noradrenaline, or midodrine [combined with octreotide]) may improve renal function in patients with type 1 HRS waiting for liver transplantation. MARS (for molecular adsorbent recirculating system) and the transjugular intrahepatic portosystemic shunt may also improve renal function in these patients. In patients with cirrhosis, acute tubular necrosis is mainly due to an ischemic insult to the renal tubules. The most common condition leading to ischemic acute tubular necrosis is severe and sustained prerenal failure. Little is known about the natural course and treatment (i.e., renal replacement therapy) of cirrhosis-associated acute tubular necrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
Arroyo, V, Ginès, P., Gerbes, A. L., Dudley, F. J., Gentilini, P., Laffi, G., Reynolds, T. B., Ring-Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,703
Sort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruiz-del-Arbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,654
Ronco, C., Bellomo, R., Homel, P., Brendolan, A., Dan, M., Piccinni, P., & La Greca, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02430-2 · Cited by 1,594
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Thadhani, R., Pascual, M., & Bonventre, J. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342207 · Cited by 1,417
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,122
Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial
(2000) · The Lancet · doi:10.1016/s0140-6736(00)03495-4 · Cited by 997
Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginès, A., Escorsell, A., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 891
Daily Hemodialysis and the Outcome of Acute Renal Failure
Schiffl, H., Lang, S. M., & Fischer, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010877 · Cited by 862
Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Schortgen, F., Lacherade, J.-C., Bruneel, F., Cattaneo, I., Hemery, F., Lemaire, F., & Brochard, L. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04211-2 · Cited by 741
Mitzner, S. R., Stange, J., Klammt, S., Risler, T., Erley, C. M., Bader, B. D., Berger, E. D., Lauchart, W., Peszynski, P., Freytag, J., et al. (2000) · Liver Transplantation · doi:10.1002/lt.500060326 · Cited by 717
A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure
Mehta, R. L., for the Collaborative Group for Treatment of ARF in the ICU, Mcdonald, B., Gabbai, F. B., Pahl, M., Pascual, M. T. A., Farkas, A., & Kaplan, R. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031154.x · Cited by 658
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
Angeli, P., Volpin, R., Gerunda, G., Craighero, R., Roner, P., Merenda, R., Amodio, P., Sticca, A., Caregaro, L., Maffei-Faccioli, A., et al. (1999) · Hepatology · doi:10.1002/hep.510290629 · Cited by 564
Nair, S., Verma, S., & Thuluvath, P. J. (2002) · Hepatology · doi:10.1053/jhep.2002.33160 · Cited by 540
Anaritide in Acute Tubular Necrosis
Allgren, R. L., Marbury, T. C., Rahman, S. N., Weisberg, L. S., Fenves, A. Z., Lafayette, R. A., Sweet, R. M., Genter, F. C., Kurnik, B. R. C., Conger, J. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703203361203 · Cited by 446
Navasa, M., Follo, A., Filella, X., Jiménez, W., Francitorra, A., Planas, R., Rimola, A., Arroyo, V., & Rodés, J. (1998) · Hepatology · doi:10.1002/hep.510270507 · Cited by 430
Hemofiltration and Peritoneal Dialysis in Infection-Associated Acute Renal Failure in Vietnam
Phu, N. H., Hien, T. T., Mai, N. T. H., Chau, T. T. H., Chuong, L. V., Loc, P. P., Winearls, C., Farrar, J., White, N., & Day, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020074 · Cited by 365
Planas, R., Bataller, R., & Rodés, J. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0032-9 · Cited by 332
Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study
Bernard, B., Cadranel, J.-F., Valla, D., Escolano, S., Jarlier, V., & Opolon, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90146-9 · Cited by 325
Cárdenas, A., Ginès, P., Uriz, J., Bessa, X., Salmerón, J. M., Mas, A., Ortega, R., Calahorra, B., De Las Heras, D., Bosch, J., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.27830 · Cited by 313
Atrial natriuretic factor in oliguric acute renal failure
Lewis, J., Salem, M. M., Chertow, G. M., Weisberg, L. S., McGrew, F., Marbury, T. C., & Allgren, R. L. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.17659 · Cited by 255
Brady, H. R., & Singer, G. G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92057-9 · Cited by 176
Prevention of Nephrotoxicity Induced by Radiocontrast Agents
Barrett, B. J., & Parfrey, P. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312111 · Cited by 173
González-Abraldes, J., Albillos, A., Bañares, R., Del Arbol, L. R., Moitinho, E., Rodríguez, C., González, M., Escorsell, A., García-Pagán, J. C., & Bosch, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26288 · Cited by 165
Acetylcysteine and Nephrotoxic Effects of Radiographic Contrast Agents — A New Use for an Old Drug
Safirstein, R. L., Andrade, L., & Vieira, J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430311 · Cited by 151
Schepke, M., Werner, E., Biecker, E., Schiedermaier, P., Heller, J., Neef, M., Caselmann, W. H., Sauerbruch, T., Stoffel‐Wagner, B., & Hofer, U. (2001) · Gastroenterology · doi:10.1053/gast.2001.26295 · Cited by 142
Moreau, R., Hadengue, A., Soupison, T., Kirstetter, P., Mamzer, M., Vanjak, D., VAUQUELIN, P., Assous, M., & Sicot, C. (1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00008 · Cited by 140
Self-citationGarcía‐Pagán, J. C., Villanueva, C., Vila, M. C., Albillos, A., Genescà, J., Ruíz-del-Árbol, L., Planas, R., Rodríguez, M., Calleja, J. L., González, A., et al. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)81028-3 · Cited by 133
García‐Pagán, J. C., Villanueva, C., Vila, M. C., et al. (2001) · PubMed · Cited by 120
Couser, W. G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06195-9 · Cited by 120
Anti-inflammatory drugs and variceal bleeding: a case-control study
de Lédinghen, V., Heresbach, D., Fourdan, O., Bernard, P., Liebaert-Bories, M. P., Nousbaum, J., Gourlaouen, A., Becker, M., Ribard, D., Ingrand, P., et al. (1999) · Gut · doi:10.1136/gut.44.2.270 · Cited by 107
New challenge of hepatorenal syndrome: Prevention and treatment
Wong, F., & Blendis, L. M. (2001) · Hepatology · doi:10.1053/jhep.2001.29200 · Cited by 98
Gentilini, P., Romanelli, R. G., Villa, G. L., Maggiore, Q., Pesciullesi, E., Cappelli, G., Raggi, V. C., Foschi, M., Marra, F., Pinzani, M., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90431-b · Cited by 94
Bataller, R. A., Ginès, P., Guevara, M., & Arroyo, V. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007201 · Cited by 89
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis
Salmerón, J. M., Arbol, L. R. D., Ginés, À., et al. (1993) · Hepatology · doi:10.1002/hep.1840170509 · Cited by 73
Moore, K. P. (1997) · Clinical Science · doi:10.1042/cs0920433 · Cited by 61
Hepatorenal syndrome in patients with cirrhosis
Moreau, R. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02778.x · Cited by 61
Self-citationRenal Hemodynamics in Patients with Cirrhosis: Relationship with Ascites and Liver Failure
Moreau, R., Gaudin, C., Hadengue, A., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187513 · Cited by 25
Self-citation
Cited by
Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,020
Self-citationEASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.024 · Cited by 2,905
Ginès, P., & Schrier, R. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0809139 · Cited by 837
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.004 · Cited by 720
Martín–Llahí, M., Pépin, M., Guevara, M., Díaz, F., Torre, A., Monescillo, A., Soriano, G., Terra, C., Fábrega, E., Arroyo, V., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.024 · Cited by 601
Metadata
- Authors
- Moreau, R., & Lebrec, D.
- Venue
- Hepatology
- Published
- 2003-02
- Volume
- 37
- Issue
- 2
- Pages
- 233-243
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2104359367
- Cited by
- 265
- References
- 46
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.